I Bartlomiejczyk
Overview
Explore the profile of I Bartlomiejczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zgoda M, Paczek L, Bartlomiejczyk I, Sieminska J, Chmielewski D, Gorecki A
Clin Rheumatol
. 2016 Aug;
26(2):284.
PMID: 27520577
No abstract available.
2.
Wyczalkowska-Tomasik A, Bartlomiejczyk I, Gornicka B, Paczek L
J Physiol Pharmacol
. 2012 Dec;
63(5):525-30.
PMID: 23211306
In diabetic nephropathy the progressive accumulation of extracellular matrix (ECM) proteins results from an imbalance between synthetic and degradative pathways. While the role of the different matrix metalloproteinases in the...
3.
Czarkowska-Paczek B, Zendzian-Piotrowska M, Bartlomiejczyk I, Przybylski J, Gorski J
J Physiol Pharmacol
. 2010 Jan;
60(4):157-62.
PMID: 20065510
The serum level of the transforming growth factor-beta1 (TGF-beta1) is elevated after acute bouts of exercise and prolonged training, as well as after myocardial infarction. However, the source of this...
4.
Zgoda M, Gorecki A, Bartlomiejczyk I, Sieminska J, Chmielewski D, Paczek L
J Musculoskelet Neuronal Interact
. 2007 Jul;
7(2):161-5.
PMID: 17627086
The aim of the study was to evaluate the relationship between the time from femoral neck fracture and the content of transforming growth factor-beta1 (TGF-beta1), interleukin-1beta (IL-1beta) and collagenase activity...
5.
Roszkowska-Blaim M, Mizerska-Wasiak M, Bartlomiejczyk I
Przegl Lek
. 2006 Aug;
63 Suppl 3:90-3.
PMID: 16898499
Unlabelled: The increase of extracellular matrix proteins synthesis including fibronectin (FN) is associated with development of renal sclerosis. The aim of the study was to examine urinary FN excretion as...
6.
Zgoda M, Paczek L, Bartlomiejczyk I, Sieminska J, Chmielewski D, Gorecki A
Clin Rheumatol
. 2006 Jul;
26(2):240-1.
PMID: 16871354
The aim of the study was to evaluate the relation between the activity of collagenase in the subchondral bone of the femoral head and the age of patients with hip...
7.
Czarkowska-Paczek B, Bartlomiejczyk I, Przybylski J
J Physiol Pharmacol
. 2006 Jul;
57(2):189-97.
PMID: 16845225
Strenuous physical exercise induces muscle fibers damage and non-specific inflammatory response. Activated by inflammatory process cells may serve as the source of wide spectrum of inflammatory mediators and growth factors....
8.
Juskowa J, Lewandowska M, Bartlomiejczyk I, Foroncewicz B, Korabiewska I, Niewczas M, et al.
Transplant Proc
. 2006 Mar;
38(1):157-60.
PMID: 16504691
Regular physical activity is usually associated with significant health benefits, but therapeutic exercise is seldom routine in renal transplant recipients. We report a randomized clinical trial of exercise training after...
9.
Bartlomiejczyk I, Zochowska D, Sanko-Resmer J, Matuszewicz D, Paczek L
Transplant Proc
. 2006 Mar;
38(1):94-6.
PMID: 16504673
Monitoring of tacrolimus blood concentrations is of utmost importance in the management of organ transplant recipients due to narrow therapeutic index of the drug and its considerable interpatient variability in...
10.
Zochowska D, Bartlomiejczyk I, Kaminska A, Senatorski G, Paczek L
Transplant Proc
. 2006 Mar;
38(1):78-80.
PMID: 16504669
Sirolimus is an immunosuppressive agent administered as prophylaxis of acute rejection to patients after kidney transplantation. Therapeutic drug monitoring (TDM) of whole blood is an important part of immunosuppressive therapy....